Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine

Completed

• Conditions: Pregnancy

• Registration Number: NCT02513043
• Lead Sponsor: Gynuity Health Projects

Brief Summary

This pilot study is designed to obtain preliminary data on the safety, acceptability, and feasibility of direct-to-consumer telemedicine abortion.

Detailed Description

The objective of this pilot study is to obtain preliminary data on the safety, acceptability, and feasibility of direct-to-consumer telemedicine abortion.

Study Timeline

• Study First Submitted: 2015-07-24
• Study First Submitted QC: 2015-07-30
• Study First Posted: 2015-07-31
• Study Start: 2016-03-22
• Status Verified: 2020-07
• Primary Completion: 2021-05-11
• Study Completion: 2021-05-11
• Last Update Submitted: 2022-02-03
• Last Update Posted: 2022-02-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 1470

Inclusion Criteria

• desires abortion

Exclusion Criteria

• medically ineligible for procedure

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of participants with adverse events as a measure of safety and tolerability	1 year	adverse events

Trial Locations

Locations (10)

Planned Parenthood of Montana; 🇺🇸 Billings, Montana, United States

Planned Parenthood Minnesota, North Dakota, South Dakota; 🇺🇸 Saint Paul, Minnesota, United States

The University of Hawaii Women's Options Centers; 🇺🇸 Honolulu, Hawaii, United States

Maine Family Planning; 🇺🇸 New York, New York, United States

Carafem; 🇺🇸 Chevy Chase, Maryland, United States

Planned Parenthood of the Rocky Mountains; 🇺🇸 New Mexico, New Mexico, United States

Emma Goldman Clinic; 🇺🇸 Iowa City, Iowa, United States

Oregon Health and Sciences University Women's Health Research Unit; 🇺🇸 Washington, Washington, United States

Choices Women's Medical Center; 🇺🇸 Jamaica, New York, United States

Planned Parenthood Columbia Willamette; 🇺🇸 Washington, Washington, United States